Melinta Therapeutics to Present at The Cowen and Company 38th Annual Health Care Conference

NEW HAVEN, Conn., March 02, 2018 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage pharmaceutical company developing and commercializing novel antibiotics to treat serious bacterial infections, announced today that its president and CEO, Dan Wechsler, will be presenting at Cowen & Company’s 38th Annual Health Care Conference in Boston, MA.